Cite
HARVARD Citation
Zhou, R. et al. (2019). Design, synthesis, and bioactivity evaluation of novel Bcl-2/HDAC dual-target inhibitors for the treatment of multiple myeloma. Bioorganic & medicinal chemistry letters. 29 (3), pp. 349-352. [Online].